Outcome of ALCL patients according to MRD in BM or PB measured by qualitative PCR results for NPM-ALK before the second course of chemotherapy. (A) CIR and Kaplan-Meier estimates of (B) 5-year EFS and (C) OS of the patients, with the initial qualitative PCR result for NPM-ALK in BM and/or blood (MDD).